These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31537027)

  • 1. Proton Pump Inhibitors and Dabigatran Therapy: Impact on Gastric Bleeding and Dabigatran Plasma Levels.
    Bolek T; Samoš M; Škorňová I; Galajda P; Staško J; Kubisz P; Mokáň M
    Semin Thromb Hemost; 2019 Nov; 45(8):846-850. PubMed ID: 31537027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.
    Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
    JAMA; 2018 Dec; 320(21):2221-2230. PubMed ID: 30512099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
    Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
    Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints.
    Zielinski GD; Teichert M; Klok FA; Rosendaal FR; Huisman MV; Cannegieter SC; Lijfering WM
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1371-1378. PubMed ID: 30443944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Proton Pump Inhibitor Withdrawal on Dabigatran Etexilate Plasma Levels in Patients With Atrial Fibrillation: A Washout Study.
    Schnierer M; Samoš M; Bolek T; Škorňová I; Nosáková L; Bánovčin P; Galajda P; Stasko J; Kubisz P; Hyrdel R; Mokáň M
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):333-335. PubMed ID: 31895873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.
    Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
    Gastroenterology; 2016 Dec; 151(6):1105-1112.e10. PubMed ID: 27639805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors for upper gastrointestinal bleeding.
    Kherad O; Restellini S; Martel M; Barkun A
    Best Pract Res Clin Gastroenterol; 2019; 42-43():101609. PubMed ID: 31785730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study.
    Staerk L; Gislason GH; Lip GY; Fosbøl EL; Hansen ML; Lamberts M; Bonde AN; Torp-Pedersen C; Olesen JB
    Europace; 2015 Aug; 17(8):1215-22. PubMed ID: 25995392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
    Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
    J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation.
    Bolek T; Samoš M; Stančiaková L; Ivanková J; Škorňová I; Staško J; Galajda P; Kubisz P; Mokáň M
    Am J Ther; 2019; 26(3):e308-e313. PubMed ID: 28452843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
    Garnock-Jones KP
    Am J Cardiovasc Drugs; 2011; 11(1):57-72. PubMed ID: 21265583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of proton pump inhibitors on blood dabigatran concentrations in Japanese patients with non-valvular atrial fibrillation.
    Kuwayama T; Osanai H; Ajioka M; Tokuda K; Ohashi H; Tobe A; Yoshida T; Masutomi T; Kambara T; Inoue Y; Nakashima Y; Asano H; Sakai K
    J Arrhythm; 2017 Dec; 33(6):619-623. PubMed ID: 29255511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy.
    Casado Arroyo R; Polo-Tomas M; Roncalés MP; Scheiman J; Lanas A
    Heart; 2012 May; 98(9):718-23. PubMed ID: 22523056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L; Chen C; White J
    Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.
    Blair HA; Keating GM
    Drugs; 2017 Mar; 77(3):331-344. PubMed ID: 28185082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
    Lazzaroni M; Porro GB
    Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of proton pump inhibitors in the management of upper gastrointestinal bleeding.
    Leontiadis GI; Howden CW
    Gastroenterol Clin North Am; 2009 Jun; 38(2):199-213. PubMed ID: 19446254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy and proton pump inhibition: cause for concern?
    Depta JP; Bhatt DL
    Curr Opin Cardiol; 2012 Nov; 27(6):642-50. PubMed ID: 23075823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding.
    Komori K; Kubokawa M; Ihara E; Akahoshi K; Nakamura K; Motomura K; Masumoto A
    World J Gastroenterol; 2017 Jan; 23(3):496-504. PubMed ID: 28210086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.